Acute respiratory distress syndrome: Difference between revisions

From IDWiki
m (Text replacement - "Clinical Presentation" to "Clinical Manifestations")
()
 
(One intermediate revision by the same user not shown)
Line 1: Line 1:
== Summary ==
+
== Background ==
   
 
* Lung damage that occurs within one week of an insult, with bilateral CXR opacities, not explain by other causes
 
* Lung damage that occurs within one week of an insult, with bilateral CXR opacities, not explain by other causes
Line 6: Line 6:
 
** V<s>T</s> 6mL/kg predicted body weight, plateau pressure ≤30 cmH<s>2</s>O, SpO2 88-95%, and pH 7.3-7.45
 
** V<s>T</s> 6mL/kg predicted body weight, plateau pressure ≤30 cmH<s>2</s>O, SpO2 88-95%, and pH 7.3-7.45
   
== Definition ==
+
=== Definition ===
   
 
* Syndrome of diffuse alveolar and interstitial edema
 
* Syndrome of diffuse alveolar and interstitial edema
 
* &quot;[https://doi.org/10.1007/s00134-005-2627-z Baby lung]&quot;: small effective lung volume, because the dependent portions are filled with fluid
 
* &quot;[https://doi.org/10.1007/s00134-005-2627-z Baby lung]&quot;: small effective lung volume, because the dependent portions are filled with fluid
   
== [https://doi.org/10.1001/jama.2012.5669 Berlin Definition (2012)] ==
+
===[https://doi.org/10.1001/jama.2012.5669 Berlin Definition (2012)]===
   
 
* Syndrome, not disease, per European task force in 2012
 
* Syndrome, not disease, per European task force in 2012
Line 18: Line 18:
 
* Chest imaging bilateral opacities not otherwise explained
 
* Chest imaging bilateral opacities not otherwise explained
 
* Severity based on oxygenation
 
* Severity based on oxygenation
** Mild: ratio of PaO<s>2</s>/FiO<s>2</s> between 200-300 with PEEP over 5 cmH<s>2</s>O (27% mortality)
+
** Mild: ratio of PaO<sub>2</sub>/FiO<sub>2</sub> between 200-300 with PEEP over 5 cmH<sub>2</sub>O (27% mortality)
** Moderate: ratio between 100 and 200 with PEEP over 5 cmH<s>2</s>O (32% mortality)
+
** Moderate: ratio between 100 and 200 with PEEP over 5 cmH<sub>2</sub>O (32% mortality)
** Severe: ratio below 100 with PEEP over 5 cmH<s>2</s>O (45% mortality)
+
** Severe: ratio below 100 with PEEP over 5 cmH<sub>2</sub>O (45% mortality)
   
== Causes ==
+
=== Etiologies ===
   
 
* Direct
 
* Direct
Line 39: Line 39:
 
** Amniotic fluid embolism
 
** Amniotic fluid embolism
   
== Pathophysiology ==
+
=== Pathophysiology ===
   
 
* Acute edema from neutrophil activation, with formation of hyaline membranes, and eventual fibrosis
 
* Acute edema from neutrophil activation, with formation of hyaline membranes, and eventual fibrosis
 
* Type I pneumocytes replaced with type II
 
* Type I pneumocytes replaced with type II
  +
* Increased alveolar permeability leading to non-hydrostatic pulmonary edema
 
* Lungs become less compliant, due to a decrease in the available lung volume
 
* Lungs become less compliant, due to a decrease in the available lung volume
  +
 
== Clinical Manifestations ==
  +
 
* Dyspnea and escalating ventilatory requirements following a known cause of ARDS
   
 
== Differential Diagnosis ==
 
== Differential Diagnosis ==
   
 
* ARDS (50%)
 
* ARDS (50%)
* Pneumonia (25%)
+
* [[Pneumonia]] (25%)
* Pulmonary edema (11%)
+
* [[Pulmonary edema]] (11%)
* Invasive aspergillosis (6%)
+
* [[Invasive aspergillosis]] (6%)
* Pulmonary embolism (3%)
+
* [[Pulmonary embolism]] (3%)
 
* Other (5%)
 
* Other (5%)
 
== Clinical Manifestations ==
 
 
* Dyspnea and escalating ventilatory requirements following a known cause of ARDS
 
   
 
== Investigations ==
 
== Investigations ==
Line 67: Line 68:
 
== Management ==
 
== Management ==
   
  +
=== All Patients ===
 
* Lung-protective ventilation (see [[ARDS ventilation protocol]])
 
* Lung-protective ventilation (see [[ARDS ventilation protocol]])
 
** Targets tidal volume of 6mL/kg predicted body weight, plateau pressure ≤30 cmH2O, SpO2 88-95%, and pH 7.3-7.45
 
** Targets tidal volume of 6mL/kg predicted body weight, plateau pressure ≤30 cmH2O, SpO2 88-95%, and pH 7.3-7.45
** Decrease tidal volume from 8mL/kg to 6mL/kg predicted body weight over 4 hours, then continue to decrease in 1mL/kg increments until plateau pressures &lt;30 or tidal volume 4mL/kg
+
** Decrease tidal volume from 8mL/kg to 6mL/kg predicted body weight over 4 hours, then continue to decrease in 1 mL/kg increments until plateau pressures &lt;30 or tidal volume 4mL/kg
** PEEP over 15 cmH<s>2</s>O [https://doi.org/10.1001/jama.2010.218 may be protective in severe ARDS]
 
** Permissive hypercapnia to CO2 60-70 and pH 7.2-7.25, if needed
 
* Prone positioning
 
 
* Maintain euvolemia
 
* Maintain euvolemia
  +
  +
=== Moderate to Severe ARDS ===
  +
  +
* Higher PEEP over 15 cmH<sub>2</sub>O
 
* Permissive hypercapnia to CO<sub>2</sub> 60-70 and pH 7.2-7.25, if needed
  +
  +
=== Severe ARDS ===
  +
 
* Prone positioning
  +
* vv-[[ECMO]]
   
 
[[Category:Critical care]]
 
[[Category:Critical care]]

Latest revision as of 22:30, 28 August 2021

Background

  • Lung damage that occurs within one week of an insult, with bilateral CXR opacities, not explain by other causes
  • Severity based on P:F ratio: severe <100, moderate 100-200, and mild 200-300
  • Lung protective ventilation reduces mortality
    • VT 6mL/kg predicted body weight, plateau pressure ≤30 cmH2O, SpO2 88-95%, and pH 7.3-7.45

Definition

  • Syndrome of diffuse alveolar and interstitial edema
  • "Baby lung": small effective lung volume, because the dependent portions are filled with fluid

Berlin Definition (2012)

  • Syndrome, not disease, per European task force in 2012
  • Timing: within 1 week of a known insult
  • Origin of edema: not cardiac or hydrostatic edema
  • Chest imaging bilateral opacities not otherwise explained
  • Severity based on oxygenation
    • Mild: ratio of PaO2/FiO2 between 200-300 with PEEP over 5 cmH2O (27% mortality)
    • Moderate: ratio between 100 and 200 with PEEP over 5 cmH2O (32% mortality)
    • Severe: ratio below 100 with PEEP over 5 cmH2O (45% mortality)

Etiologies

  • Direct
    • Pneumonia
    • Aspiration
    • Inhalational injury
    • Pulmonary contusion
    • Near-drowning
  • Indirection
    • Sepsis
    • Major trauma
    • Multiple blood product transfusions
    • Pancreatitis
    • Shock
    • Drug overdose
    • Amniotic fluid embolism

Pathophysiology

  • Acute edema from neutrophil activation, with formation of hyaline membranes, and eventual fibrosis
  • Type I pneumocytes replaced with type II
  • Increased alveolar permeability leading to non-hydrostatic pulmonary edema
  • Lungs become less compliant, due to a decrease in the available lung volume

Clinical Manifestations

  • Dyspnea and escalating ventilatory requirements following a known cause of ARDS

Differential Diagnosis

Investigations

  • Chest x-ray showing bilateral infiltrates
  • Bronchoalveolar lavage (BAL)
    • Excludes the diagnosis if less than 5% neutrophils (can be over 80% in ARDS)
    • Suggestive if lavage to plasma protein ratio > 0.7 (less than 0.5 in hydrostatic edema)

Management

All Patients

  • Lung-protective ventilation (see ARDS ventilation protocol)
    • Targets tidal volume of 6mL/kg predicted body weight, plateau pressure ≤30 cmH2O, SpO2 88-95%, and pH 7.3-7.45
    • Decrease tidal volume from 8mL/kg to 6mL/kg predicted body weight over 4 hours, then continue to decrease in 1 mL/kg increments until plateau pressures <30 or tidal volume 4mL/kg
  • Maintain euvolemia

Moderate to Severe ARDS

  • Higher PEEP over 15 cmH2O
  • Permissive hypercapnia to CO2 60-70 and pH 7.2-7.25, if needed

Severe ARDS

  • Prone positioning
  • vv-ECMO